Apart from selling premium, medical grade cannabis flower with known genetics, Institute for Medical Cannabis manufactures pharmaceutical products with consistent cannabinoid profiles. Products are created with pure, fractionated cannabinoids and terpenes. Separation of the cannabinoids allows us to use pure active ingredients for accurate dosing. These formulations are available for patients who require exact dosing for their condition management. Many patients, including epileptic pediatrics, depend on specific ratios to complement their treatments, especially when using cannabinoid medicine in combination with heavy pharmaceutical regimes. Our formulations will allow patients and their physicians to record and analyze progress in disease management.
All our formulations are developed to comply with all laws, regulations and industry guidelines. Active cannabinoids are combined with inactive excipients for use in multiple delivery systems. The initial roster of delivery systems includes:
- Gel capsules
- Sublingual tinctures
- Orally disintegrating tablets
- Topical ointments
- Pre-filled oil dispensers